SynthesisFrontiers in endocrinology2025
Association between weight-adjusted waist index and cardiovascular disease: a systematic review and meta-analysis.
Synthesis in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The increasing global prevalence of obesity and cardiovascular disease (CVD) represents a pressing public health challenge. Traditional obesity metrics, such as body mass index (BMI) and waist circumference (WC), have limitations in accurately predicting CVD risk. The weight-adjusted waist index (WWI), a novel metric combining WC and body weight, has been proposed as an alternative predictor of central obesity and its associated risks. This systematic review and meta-analysis aimed to evaluate the association between WWI and CVD. Methods: We conducted a systematic review of the literature in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and the study was registered with PROSPERO (ID CRD42024629861), searching PubMed, Scopus, and Google Scholar for observational studies examining the relationship between WWI and CVD. Data extraction and quality assessment were performed independently by two reviewers. A random-effects meta-analysis and subgroup analyzes were conducted to pool effect sizes, expressed as adjusted odds ratios (aORs) or adjusted hazard ratios (aHRs), and heterogeneity was evaluated using I², T², and Q statistics. Results: Ten studies comprising 170,297 participants were included. The pooled analysis revealed a significant positive association between WWI and increased CVD risk, with a pooled OR of 1.33 (95% CI: 1.17-1.48, Conclusions: This study suggests a potential association between WWI and CVD, supporting its utility as an alternative measure of central obesity compared to traditional metrics. Despite these findings, moderate heterogeneity warrants further investigation into population-specific factors and mechanisms underlying the relationship between WWI and CVD. Future research should validate these findings across diverse populations and explore the clinical applications of WWI in CVD prevention strategies. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024629861.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.